Despite a rash of pessimism, HCPs remain engageable. Marketers must utilize open medical education hubs and CME town halls — among other tactics — to make content more engaging.
Following massive strikes by Opdivo and Keytruda, will more supersized campaigns follow?
More has been written about millennials — and their healthcare habits — than about any other generation. Here, Gen Y marketers explain why most of what you’ve read is wrong.
Recruitment for clinical trials has never been easy. New tools and tactics could change that — assuming the sheer volume of information doesn’t overwhelm trial organizers.
Two recent cash infusions suggest investors are bullish on point-of-care advertising. Is the channel ready for its moment in the spotlight?
Frustrated by its inability to empathize with patients, pharma has turned to tech to teach providers and caregivers what illness really feels like.
Managing director Jedd Davis reports that growth continues to exceed expectations.
Stilt walkers. That’s the metaphor president Dan Renick is kicking around to symbolize Precision For Value’s 2016.
LevLane enjoyed other successes on the client front, which spurred a small bump in revenue to $8.9 million in 2016, up 3.5% from 2015.
All things considered, Invivo president Andrea Bielecki considers 2016 “a good year, with lots of learning and many opportunities.”
